Patients with severe COVID-19 display low induction of systemic and local (i.e., in the airway epithelium) IFN secretion (59) in the early phases, which traces back to a hypo responsiveness of IFN-producing plasmacytoid dendritic cells to viral infection (60). This evidence concerns the gene IFNA1 and COVID-19.